[1] Mao JX, Teng F, Yuan H, et al. Primary hepatic squamous cell carcinoma with abdominal incision metastasis after hepatectomy. Hepatobiliary Pancreat Dis Int, 2019,18(2): 194-198.
[2] Steffani K, Erbersdobler A, Broering DC. Primary squamous cell carcinoma of the liver. Surprising findings in dysontogenetic liver cysts. Dtsch Med Wochenschr, 2003,128(38): 1947-1950.
[3] Zhu KL, Li DY, Jiang CB. Primary squamous cell carcinoma of the liver associated with hepatolithiasis: a case report. World J Gastroenterol, 2012,18(40): 5830-5832.
[4] Yamao K, Takenaka M, Imai H, et al. Primary hepatic adenosquamous carcinoma associated with primary sclerosing cholangitis. Oncology, 2017,93 Suppl 1: 76-80.
[5] Sun Y, Jin G. Primary squamous cell carcinoma of the liver: a case report. J Int Med Res, 2021,49(6): 675885093.
[6] Kobayashi M, Okabayashi T, Okamoto K, et al. A clinicopathologic study of primary adenosquamous carcinoma of the liver. J Clin Gastroenterol, 2005,39(6): 544-548.
[7] Gou Q, Fu S, Xie Y, et al. Treatment and survival patterns of primary adenosquamous carcinoma of the liver: a retrospective analysis. Front Oncol, 2021,11: 621594.
[8] Nakai T, Ono K, Terayama K, et al. Case report: adenosquamous carcinoma of the liver successfully treated with repeated transcatheter arterial infusion chemotherapy (TACE) with degradable starch microspheres. Br J Radiol, 2004,77(918): 516-518.
[9] Wang K, Lu C, Sun J N, et al. Primary hepatic squamous cell carcinoma with high microsatellite instability shows good response to programmed cell death 1 inhibitor as adjuvant therapy. Hepatology, 2021,74(3): 1695-1697. |
